PNPLA2 and obesity due to melanocortin 4 receptor deficiency: For example, small-molecule ligands for a potent activator of ATGL can boost lipolysis in adipose and muscle tissue, and it has been argued that they might be developed into therapeutic entities for obesity and diabetes [65].